Why Boston Scientific (BSX) Outpaced the Stock Market Today

Boston Scientific (BSX) closed at $42.73, up 1.64% on the day, outperforming the S&P 500. The company is expected to report earnings on October 28, 2026, with predicted EPS of $0.76 (+1.33% YoY) and revenue of $5.17 billion (+2.12% YoY). However, BSX holds a Zacks Rank #4 (Sell) rating due to a 1.3% decline in consensus EPS estimates over the past month. The stock trades at a Forward P/E of 12.92, below its industry average, but faces headwinds despite valuation appeal.